医学大麻图书馆:开发一个精心策划的数据库,用于关于大麻治疗活动的研究文章
Dmitry Rodin1, Yael Maizels2, Igor Koman3
1Institute for Personalized and Translational Medicine, Ariel University, Ariel, Israel. rodin.dmitry@icloud.com.
Journal of cannabis research
|July 7, 2025
概括
医用大麻图书馆 (MCL) 是一个新的数据库,它组织了11000多项关于大麻治疗的研究. 它可以帮助研究人员轻松找到有关大麻素及其对各种疾病的影响的信息.
科学领域:
- 药理学 药理学是指药理学的学科.
- 医疗信息学 医疗信息学
- 基于证据的医学基于证据的医学.
背景情况:
- 导航大麻研究的广泛和可变质量对医疗保健专业人员和研究人员来说是一个重大挑战.
- 需要一个集中,精心策划的资源,以有效地访问和解释有关大麻素治疗潜力的发现.
研究的目的:
- 推出医疗大麻图书馆 (MCL),这是一个新的数据库,旨在简化大麻相关治疗研究的发现.
- 提供一个用户友好的平台来访问和分析关于大麻素的医学应用的科学文献.
主要方法:
- 来自PubMed的11000多个相关出版物的整合,特别关注治疗性大麻素.
- 开发一个先进的搜索界面,通过疾病,条件,症状,综合征和特定的大麻素来检索信息.
- 应用自然语言处理来分类大麻素与疾病之间的关系 (正,负,中性).
主要成果:
- MCL成功地汇集了大量的医用大麻文献,使其更容易获得.
- 先进的搜索和分类功能促进了有效的信息检索和理解大麻素条件关系.
- 该数据库对超过11000篇出版物进行了分类,为医用大麻的治疗领域提供了洞察力.
结论:
- 医学大麻图书馆 (MCL) 在组织和获取医学大麻研究的科学知识方面取得了重大进展.
- 该工具使医疗保健专业人员能够更好地了解大麻素在各种临床适应症中的治疗潜力.
- 该MCL通过提供一个结构化和可搜索的大麻治疗研究库来促进基于证据的决策.
相关概念视频
Therapeutic Index
5.1K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
5.1K
Drug Discovery: Overview
8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Preclinical Development: Overview
4.9K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.9K
Drug Regulation
1.9K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.9K
Targets for Drug Action: Overview
7.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.5K
Drugs Affecting Neurotransmitter Release or Uptake
1.2K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.2K


